Generable Revenue and Competitors
Estimated Revenue & Valuation
- Generable's estimated annual revenue is currently $290k per year.
- Generable's estimated revenue per employee is $72,500
Employee Data
- Generable has 4 Employees.
- Generable grew their employee count by 0% last year.
Generable's People
Name | Title | Email/Phone |
---|---|---|
1 | Founder and CEO (Techstars '17) | Reveal Email/Phone |
2 | Head Data and Analytics | Reveal Email/Phone |
Generable Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $22.6M | 142 | -18% | N/A | N/A |
#2 | $41.3M | 259 | 44% | N/A | N/A |
#3 | $808.8M | 3984 | 9% | N/A | N/A |
#4 | $1320M | 1901 | 8% | $445M | N/A |
#5 | $513.8M | 2478 | 11% | $215M | N/A |
#6 | $16.7M | 115 | 4% | N/A | N/A |
#7 | $469.4M | 2264 | 8% | $298.8M | N/A |
#8 | $84.3M | 465 | 33% | N/A | N/A |
#9 | $19.4M | 127 | -2% | $46.6M | N/A |
#10 | $81.2M | 448 | 25% | N/A | N/A |
What Is Generable?
The Generable platform is utilizing the latest advances in probabilistic programming, Bayesian inference, and multi-level regression and poststratification (MRP) for dose optimization, making go/no-go decisions from early clinical data, assessing the predictive power of biomarkers, and performing principled subgroup analysis. Our cloud-based, analytics-ready database and inference API makes it easy to produce and reproduce analyses without worrying about IT infrastructure configuration and maintenance. We are currently working with a small number of beta customers in Immuno-Oncology. Generable originated from the open-source Stan (mc-stan.org) project at Columbia University.
keywords:N/AN/A
Total Funding
4
Number of Employees
$290k
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.1M | 4 | -56% | $30M |
#2 | N/A | 4 | N/A | N/A |
#3 | $0.4M | 4 | 0% | N/A |
#4 | $0.3M | 4 | -20% | N/A |
#5 | $0.3M | 4 | -43% | N/A |